In conclusion, this nationwide data mining analysis-based study identified treatment for HCC, the serum albumin level, and the TNM stage as significant long-term prognostic factors among patients with NAFLD-HCC. This evidence concerns the gene ALB and metabolic dysfunction-associated steatotic liver disease.